Lilly to further investigate retatrutide for the treatment of obesity in the TRIUMPH phase 3 clinical program
Oncodesign Services and ImaginAb sign a Preclinical License and Supply Agreement
This request for withdrawal of the two dossiers was made after necessary consultations and receiving guidance from EMA
The company expects to capture a 10 per cent share in Spain’s $6.34 million meropenem market and consolidate its position in other European countries
The group now has 372 approvals and has so far filed over 442* ANDAs since the commencement of the filing process in FY 2003-04.
Laurus will also provide funding for the clinical trials and will launch these products in India and emerging markets
Cullgen will have the option during the initial stages of clinical development to participate equally in the costs, profits and losses
Acquisition delivers industry-leading research capability, and strengthens pipeline with a novel candidate for ulcerative colitis, Crohn’s disease and other autoimmune conditions
Based on a subgroup analysis by PD-L1 expression from KEYNOTE-811, Merck is working with the US FDA to update the current indication for KEYTRUDA in HER2-positive gastric or GEJ adenocarcinoma
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
